PTOV-1, a novel protein overexpressed in prostate cancer, shuttles between the cytoplasm and the nucleus and promotes entry into the S phase of the cell division cycle

American Journal of Pathology

Volumn 162, Issue 3, 2003, Pages 897-905

  Santamaría, Anna ^a   Fernández, Pedro L ^b   Farré, Xavier ^b   Benedit, Patricia ^a   Reventós, Jaume ^a   Morote, Juan ^a   Paciucci, Rosanna ^a   Thomson, Timothy M ^a,c  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c INSTITUT DE BIOLOGIA MOLECULAR DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; GENE PRODUCT; GREEN FLUORESCENT PROTEIN; KI 67 ANTIGEN; PROTEIN PTOV1; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ANIMAL CELL; ARTICLE; CELL CYCLE S PHASE; CELL LINE; CELL NUCLEUS; CELL PROLIFERATION; CELL STRAIN; CELL STRAIN COS7; CONTROLLED STUDY; CYTOPLASM; FLOW CYTOMETRY; FLUORESCENCE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MITOSIS; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN TRANSPORT;

EID: 0345505669     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63885-0     Document Type: Article

References (38)

1. Jenster G: The role of the androgen receptor in the development and progression of prostate cancer. Semin Oncol 1999, 26:407-421
2. Grossmann ME, Huang H, Tindall DJ: Androgen receptor signaling in androgen-refractory prostate cancer. J Natl Cancer Inst 2001, 93:1687-1697
3. Marcelli M, Ittmann M, Mariani S, Sutherland R, Nigam R, Murthy L, Zhao Y, DiConcini D, Puxeddu E, Esen A, Eastham J, Weigel NL, Lamb DJ: Androgen receptor mutations in prostate cancer. Cancer Res 2000, 60:944-949
4. Linja MJ, Savinainen KJ, Saramaki OR, Tammela TL, Vessella RL, Visakorpi T: Amplification and overexpression of androgen receptor gene in hormone-refractory prostate cancer. Cancer Res 2001, 61:3550-3555
5. Taplin ME, Bubley GJ, Shuster TD, Frantz ME, Spooner AE, Ogata GK, Keer HN, Balk SP: Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer. N Engl J Med 1995, 332:1393-1398
6. Klein KA, Reiter RE, Redula J, Moradi H, Zhu XL, Brothman AR, Lamb DJ, Marcelli M, Belldegrun A, Witte ON, Sawyers CL: Progression of metastatic human prostate cancer to androgen independence in immunodeficient SCID mice. Nat Med 1997, 3:402-408
7. Blok LJ, Kumar MV, Tindall DJ: Isolation of cDNAs that are differentially expressed between androgen-dependent and androgen-independent prostate carcinoma cells using differential display PCR. Prostate 1995, 26:213-224
8. Chang GT, Blok LJ, Steenbeek M, Veldscholte J, van Weerden WM, van Steenbrugge GJ, Brinkmann AO: Differentially expressed genes in androgen-dependent and -independent prostate carcinomas. Cancer Res 1997, 57:3814-3822
9. Lucas S, De Smet C, Arden KC, Viars CS, Lethe B, Lurquin C, Boon T: Identification of a new MAGE gene with tumor-specific expression by representational difference analysis. Cancer Res 1998, 58:743-752
10. Stubbs AP, Abel PD, Golding M, Bhangal G, Wang Q, Waxman J, Stamp GW, Lalani EN: Differentially expressed genes in hormone refractory prostate cancer: association with chromosomal regions involved with genetic aberrations. Am J Pathol 1999, 154:1335-1343
11. Lin B, Ferguson C, White JT, Wang S, Vessella R, True LD, Hood L, Nelson PS: Prostate-localized and androgen-regulated expression of the membrane-bound serine protease TMPRSS2. Cancer Res 1999, 59:4180-4184
12. Xu J, Stolk JA, Zhang X, Silva SJ, Houghton RL, Matsumura M, Vedvick TS, Leslie KB, Badaro R, Reed SG: Identification of differentially expressed genes in human prostate cancer using subtraction and microarray. Cancer Res 2000, 60:1677-1682
13. Luo JH, Yu YP, Cleply K, Lin F, Deflavia P, Dhir R, Finkelstein S, Michalopoulos G, Becich M: Gene expression analysis of prostate cancers. Mol Carcinog 2001, 33:25-35
14. Chaib H, Rubin MA, Mucci NR, Li L, Taylor JMG, Day ML, Rhim JS, MaCoska JA: Activated in prostate cancer: a PDZ domain-containing protein highly expressed in human primary prostate tumors. Cancer Res 2001, 61:2390-2394
15. Chetcuti A, Margan S, Mann S, Russell P, Handeslman D, Rogers J, Dong Q: Identification of differentially expressed genes in organconfined prostate cancer by gene expression array. Prostate 2001, 47:132-140
16. Dhanasekaran SM, Barrette TR, Ghosh D, Shah R, Varambally S, Kurachi K, Pienta KJ, Rubin MA, Chinnaiyan AM: Delineation of prognostic biomarkers in prostate cancer. Nature 2001, 412:822-826
17. Welsh JB, Sapinoso LM, Su AI, Kern SG, Wang-Rodriguez J, Moskaluk CA, Frierson Jr HF, Hampton GM: Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer. Cancer Res 2001, 61:5974-5978
18. Singh D, Febbo PG, Ross K, Jackson DG, Manola J, Ladd C, Tamayo P, Renshaw AA, D'Amico AV, Richie JP, Lander ES, Loda M, Kantoff PW, Golub TR, Sellers WR: Gene expression correlates of clinical prostate cancer behavior. Cancer Cell 2002, 1:203-209
19. Ernst T, Hargenhahn M, Kenzelmann M, Cohen CD, Bomrouhi M, Weninger A, Klären R, Gröne EF, Wiesel M, Güdemann C, Küstler J, Schott W, Staehler G, Kretzler M, Hollstein M, Gröne H-J: Decrease and gain of gene expression are equally discriminatory markers for prostate carcinoma. Am J Pathol 2002, 160:2169-2180
20. Benedit P, Paciucci R, Thomson TM, Valeri M, Nadal M, Càceres C, de Torres I, Estivill X, Lozano JJ, Morote J, Reventos J: PTOV1, a novel protein overexpressed in prostate cancer containing a new class of protein homology blocks. Oncogene 2001, 20:1455-1464
21. Fernández PL, Nayach I, Fernández E, Fresno L, Palacin A, Farré X, Campo E, Cardesa A: Tissue macroarrays ("microchops") for gene expression analysis. Virchows Arch 2001, 438:591-594
22. Fernández PL, Arce Y, Farré X, Martínez A, Nadal A, Rey MJ, Peiró N, Campo E, Cardesa A; Expression of p27/kip1 is down-regulated in human prostate carcinoma progression. J Pathol 1999, 187:563-566
23. Gerdes J, Lemke H, Baisch H, Wacker H-H, Schwab U, Stein H: Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 1984, 133:1710-1715
24. Sherr C, Roberts JM: CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 1999, 13:1501-1512
25. Guo Y, Lklar GN, Borkowski A, Kyprianou N: Loss of the cyclin-dependent kinase inhibitor p27(Kip1) protein in human prostate cancer correlates with tumor grade. Clin Cancer Res 1997, 3:2269-2274
26. Cordon-Cardo C, Koff A, Drobnjak M, Capidieci P, Osman I, Millard SS, Gaudin PB, Fazzari M, Zhang ZF, Massague J, Scher HI: Distinct altered patterns of p27KIP1 gene expression in benign prostatic hyperplasia and prostatic carcinoma. J Natl Cancer Inst 1998, 90:1284-1291
27. Verheijen R, Kuijpers HJ, van Driel R, Beck JL, van Dierendonck JH, Brakenhoff GJ, Ramaekers FC: Ki-67 detects a nuclear matrix-associated proliferation-related antigen. II. Localization in mitotic cells and association with chromosomes. J Cell Sci 1989, 92:531-540
28. Baldin V, Lukas J, Marcote J, Pagano M, Draetta G: Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev 1993, 7:812-821
29. Diehl JA, Cheng M, Roussel MF, Sherr CJ: Glycogen synthase kinase-3b regulates cyclin D1 proteolysis and subcellular localization. Genes Dev 1998, 12:3499-3511
30. Yang J, Kornbluth S: All aboard the cyclin train: subcellular trafficking of cyclins and their CDK partners. Trends Cell Biol 1999, 9:207-210
31. Naar AM, Beaurang PA, Zhou S, Abraham S, Solomon W, Tjian R: Composite co-activator ARC mediates chromatin-directed transcriptional activation. Nature 1999, 398:828-832
32. Douglas TH, Morgan TO, McLeod DG, Moul JW, Murphy GP, Barren III R, Sesterhenn IA, Mostofi FK: Comparison of serum prostate specific membrane antigen, prostate specific antigen, and free prostate specific antigen levels in radical prostatectomy patients. Cancer 1997, 80:107-114
33. Chen RH, Sarnbecki C, Blenis J: Nuclear localization and regulation of ERK- and RSK-encoded protein kinases. Mol Cell Biol 1992, 12:915-927
34. Brunet A, Roux D, Lenormand P, Dowd S, Kayse S, Pouysségur J: Nuclear translocation of p43/p44 mitogen-activated protein kinase is required for growth factor-induced gene expression and cell cycle entry. EMBO J 1999, 18:664-674
35. Pines J, Hunter T: Human cyclins A and B1 are differentially located in the cell and undergo cell cycle-dependent nuclear transport. J Cell Biol 1991, 115:1-17
36. Takizawa CG, Morgan DO: Control of mitosis by changes in the subcellular location of cyclin-B1-Cdk1 and Cdc25C. Curr Opin Cell Biol 2000, 12:658-665
37. Alt JR, Gladden AB, Diehl JA: p21Cip1 promotes cyclin D1 nuclear accumulation via direct inhibition of nuclear export. J Biol Chem 2002, 277:8517-8523
38. Diehl JA, Sherr CJ: A dominant-negative cyclin D1 mutant prevents nuclear import of cyclin-dependent kinase 4 (CDK4) and its phosphorylation by CDK-activating kinase. Mol Cell Biol 1997, 17:7362-7374